BUB1B knockdown could decrease the glycolysis-related genes, including solute carrier family 2 number 1, LDHA, pyruvate kinase M 2, and hexokinase 2, suggesting that BUB1B acts as an activator in glycolytic metabolism to promote lung adenocarcinoma [24]. This evidence concerns the gene LDHA and lung adenocarcinoma.